GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )

NCT02994836 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

139

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease
Inflammatory Bowel Disease
Ulcerative Colitis

Interventions

BIOLOGICAL: Anti-TNF: Infliximab (Infusion)
DRUG: Anti-TNF discontinuation: Physiological saline solution
BIOLOGICAL: Anti-TNF:Adalimumab (Subcutaneus)
DRUG: Anti-TNF discontinuation: Physiological saline solution

Sponsor

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa